Skip to content

Clinical trials

Phase 1 Diabetes Mellitus, Type 2 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 1 Country / region: Japan Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20062
20073
20094
20102
20111
20123
20142
20151
20161
20171
20181
20203
20212
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S10
AstraZeneca7
Eli Lilly and Company6
Pfizer3
Astellas Pharma Inc2
Boehringer Ingelheim1
Bristol-Myers Squibb1
GlaxoSmithKline1
Janssen Pharmaceutical K.K.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 234
Diabetes Mellitus15
Obesity2
Endocrine System Diseases1
Glucose Metabolism Disorders1
Metabolic Diseases1
Renal Insufficiency1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.